Skip to main content

Insulin and vaccine cost-sharing for 2023

 

The changes below are included in the 2023 Inflation Reduction Act.

 

Insulin cost-sharing

 

Starting January 1, 2023, people enrolled in a Medicare Prescription Drug Plan (Medicare Part D Plan) will not pay more than $35 for a month’s supply of each type of insulin that they take. The insulin must be covered by their Medicare Part D Plan and dispensed at a pharmacy or through a mail-order pharmacy. Medicare Part D deductibles will not apply to the covered insulin product.

 

Starting July 1, 2023, people enrolled in the Medicare Advantage Plan who take insulin through a traditional pump will not pay more than $35 for a month’s supply of covered insulin, and the deductible will not apply to the insulin. This rule will apply to people using pumps covered through the durable medical equipment (DME) benefit under Part B vaccine cost-sharing.

 

The beneficiaries of the Medicare Advantage Plan (effective July 1, 2023) and the Medicare Prescription Drug Plan (effective January 1, 2023) will not pay more than $35 for a month’s supply of covered insulin regardless of whether they have met their deductible.

 

Vaccine cost-sharing

 

Starting January 1, 2023, adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP), including the shingles vaccine, will be available to people with Medicare Part D at no extra cost to them.

 

For more information

 

Legal notices

Aetna is the brand name used for products and services provided by one or more of the Aetna group of companies, including Aetna Life Insurance Company and its affiliates (Aetna).

Health benefits and health insurance plans contain exclusions and limitations.

Also of interest: